Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

When experienced researcher Renato Aguilera happened across the chemical structure of a tried-and-true antimalarial drug one ...

Epigenetics are one of life's primary drivers of adaptations. They are why human beings who live at high altitude have more ...

BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...

President of the Pharmaceutical Society of Nigeria, Tanko Ayuba, speaks to AJIBADE OMAPE on the widespread nature of counterfeit, unregistered, and expired pharmaceutical products and how they pose a ...

Can a drug that’s used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso (UTEP) have secured a patent for the anti-malarial drug pyronaridine to do just ...

The Trump administration canceled on Thursday around 90% of contracts funded by the U.S. Agency for International Development ...

The use of artificial intelligence in drug discovery marks a significant shift in how scientists approach finding treatments ...

The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers from Children's Hospital of Philadelphia (CHOP) discovered a key process ...

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that.